Xior Student Housing NV (EBR:XIOR)

Blueprint Medicines Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 12, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,445	1,256	1,058	810	1,363	1,033
Market Cap Growth	16.57%	18.68%	30.68%	-40.59%	31.87%	6.95%
Enterprise Value	2,930	2,672	2,505	1,620	2,153	1,665
Last Close Price	30.95	28.38	27.07	25.68	42.57	40.85
PE Ratio	22.62	18.88	-	4.34	16.56	-
PS Ratio	6.77	6.10	5.52	6.04	14.30	14.53
PB Ratio	0.83	0.77	0.70	0.55	1.36	1.57
P/OCF Ratio	18.96	22.20	40.56	110.88	50.52	313.91
EV/Sales Ratio	13.73	12.98	13.08	12.08	22.60	23.42
EV/EBITDA Ratio	37.35	26.39	23.34	39.53	76.83	59.03
EV/EBIT Ratio	37.46	26.47	23.47	39.74	77.29	59.43
Debt / Equity Ratio	0.85	0.88	0.95	0.88	0.73	1.12
Debt / EBITDA Ratio	18.99	14.25	13.37	31.91	26.22	26.26
Asset Turnover	0.06	0.06	0.06	0.05	0.05	0.05
Quick Ratio	0.25	0.26	0.07	0.10	0.08	0.14
Current Ratio	0.55	0.56	0.20	0.28	0.41	0.43
Return on Equity (ROE)	3.62%	4.22%	-0.63%	14.98%	9.90%	-6.50%
Return on Assets (ROA)	1.36%	1.82%	2.02%	0.96%	0.94%	1.21%
Return on Capital (ROIC)	1.56%	2.09%	2.32%	1.12%	1.11%	1.38%
Earnings Yield	4.20%	5.30%	-0.89%	23.04%	6.04%	-4.04%
Dividend Yield	5.71%	6.23%	6.42%	6.45%	3.38%	3.33%
Payout Ratio	45.88%	69.85%	-	13.20%	32.51%	-
Buyback Yield / Dilution	-12.85%	-10.71%	-23.78%	-21.75%	-25.99%	-30.44%
Total Shareholder Return	-7.16%	-4.47%	-17.36%	-15.31%	-22.61%	-27.11%

Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.